Position in ARGX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,330,694
+$590,066 QoQ
Shares Held
3,590
-4.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#171
of 504 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Common Asset Management, LLC holds $13,013,451 across 2 Biotechnology names. ARGX ranks #2 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,493 | $9,682,757 | |
| 2 | ARGX |
Argenx SE
This page
|
3,590 | $3,330,694 |
All Filings in ARGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,330,694 | 3,590 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,740,628 | 3,753 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||